SUBOXONE (BUPRENORPHINE AND NALOXONE) C SUBLINGUAL FILM Trademark

Trademark Overview

On Thursday, January 12, 2023, a trademark application was filed for SUBOXONE (BUPRENORPHINE AND NALOXONE) C SUBLINGUAL FILM with the United States Patent and Trademark Office. The USPTO has given the SUBOXONE (BUPRENORPHINE AND NALOXONE) C SUBLINGUAL FILM trademark a serial number of 97751615. The federal status of this trademark filing is REGISTERED as of Tuesday, February 18, 2025. This trademark is owned by INDIVIOR UK LIMITED. The SUBOXONE (BUPRENORPHINE AND NALOXONE) C SUBLINGUAL FILM trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Provision of health care advice; providing information relating to opioid dependence
suboxone (buprenorphine and naloxone) c sublingual film

General Information

Serial Number97751615
Word MarkSUBOXONE (BUPRENORPHINE AND NALOXONE) C SUBLINGUAL FILM
Filing DateThursday, January 12, 2023
Status700 - REGISTERED
Status DateTuesday, February 18, 2025
Registration Number7698308
Registration DateTuesday, February 18, 2025
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, November 14, 2023

Trademark Statements

Description of MarkThe mark consists of the stylized word "SUBOXONE". The chemical name of the mark "(BUPRENORPHINE AND NALOXONE)" appears underneath the word "SUBOXONE". To the right of the chemical name is a stylized "C" with three vertical lines inside, followed by the words "SUBLINGUAL FILM".
Pseudo MarkSUBOXONE (BUPRENORPHINE AND NALOXONE) CIII SUBLINGUAL FILM
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesProvision of health care advice; providing information relating to opioid dependence
NOT AVAILABLE"BUPRENORPHINE AND NALOXONE", "SUBLINGUAL FILM", and the Schedule III Controlled Substance symbol

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, February 2, 2023
Primary Code044
First Use Anywhere DateFriday, September 3, 2010
First Use In Commerce DateFriday, September 3, 2010

Trademark Owner History

Party NameINDIVIOR UK LIMITED
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressPriory Park, Hull HU47DY
GB
Party NameINDIVIOR UK LIMITED
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressPriory Park, Hull HU47DY
GB
Party NameINDIVIOR UK LIMITED
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressPriory Park, Hull HU47DY
GB

Trademark Events

Event DateEvent Description
Monday, January 16, 2023NEW APPLICATION ENTERED
Thursday, February 2, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, February 3, 2023NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, August 30, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, August 30, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, August 30, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, August 31, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED
Thursday, August 31, 2023WITHDRAWAL OF ATTORNEY GRANTED
Monday, September 18, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, September 18, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, September 18, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, September 18, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, September 18, 2023TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Monday, September 18, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, September 23, 2023ASSIGNED TO EXAMINER
Tuesday, October 10, 2023EXAMINERS AMENDMENT -WRITTEN
Tuesday, October 10, 2023EXAMINERS AMENDMENT E-MAILED
Tuesday, October 10, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, October 10, 2023EXAMINER'S AMENDMENT ENTERED
Tuesday, October 10, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 25, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 14, 2023PUBLISHED FOR OPPOSITION
Tuesday, November 14, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 9, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, June 20, 2024USE AMENDMENT FILED
Thursday, August 8, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, August 9, 2024STATEMENT OF USE PROCESSING COMPLETE
Thursday, June 20, 2024TEAS STATEMENT OF USE RECEIVED
Tuesday, October 8, 2024NON-FINAL ACTION E-MAILED
Friday, January 24, 2025EXAMINERS AMENDMENT E-MAILED
Friday, January 24, 2025NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, January 24, 2025NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, January 24, 2025SU-EXAMINER'S AMENDMENT WRITTEN
Friday, January 24, 2025EXAMINER'S AMENDMENT ENTERED
Friday, January 24, 2025ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, February 18, 2025REGISTERED-PRINCIPAL REGISTER
Tuesday, February 18, 2025NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, October 8, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, October 8, 2024SU - NON-FINAL ACTION - WRITTEN

Related Keywords

film sublingual naloxone buprenorphine suboxone relating opioid dependence information providing health care advice provision